Search by Faculty Member
Search by Sub-Specialty
North America – United States
Ronney Abaza, MD
Sub-Specialty Areas: Robotic Prostate, Kidney, Ureter, Adrenal, and Bladder Surgery
Dr. Ronney Abaza is Director of Robotic Surgery at OhioHealth Dublin Methodist Hospital. His practice and academic interests are dedicated solely to robotic surgery. Dr. Abaza has performed approximately 3,000 robotic operations since 2006 for conditions of the prostate, kidneys, ureters, adrenal glands, and bladder. He has led the development of multidisciplinary robotic surgery programs at three institutions. Dr. Abaza is an innovator in robotic surgery as the first in the world to perform robotic surgery for adrenocortical carcinoma, kidney cancer with caval thrombi, ureteroileal anastomosis revisions after cystectomy, and renal auto transplantation. He has presented his work at national and international meetings, including more than 100 presentations on robotic surgery in the past three years, and has won numerous awards for his research. He is director of a robotic urologic surgery fellowship program.
Dean Assimos, MD
Sub-Specialty Areas: Kidney Stones and Endourology
Dr. Dean George Assimos is currently Professor of Surgical Sciences and Vice-chair of the Department of Urology at Wake Forest University School of Medicine. He obtained a BS degree in biology from Purdue University in 1974 and an MD degree from Loyola University of Chicago in 1977. He subsequently completed his urology residency at Northwestern University in 1983. He was a fellow in intra-renal surgery and kidney stone disease at Wake Forest University in 1984 after which he was an AUA research scholar at the same institution from 1984-1986.
He has dedicated his career to the care of patients afflicted with complex renal stone disease including medical and surgical management. He has conducted clinical, translational and basic science research focusing on factors which impact urinary oxalate excretion. He and his research colleagues have received steady funding from the NIH for these endeavors. They have demonstrated the important contribution of dietary oxalate to the urinary oxalate pool, defined the importance of interactions between dietary calcium and oxalate, and characterized mechanisms of gastrointestinal oxalate absorption and endogenous oxalate synthesis. He is the author of numerous papers and chapters pertaining to these subjects. He has served as a member of the AUA Nephrolithiasis Guidelines Panel since its inception and is currently the Vice-chair of this committee. Dr. Assimos is on the editorial board of several urologic journals. He is also committed to urologic education participating as a speaker and course director for the AUA and other organizations.
Anthony Atala, MD
Sub-Specialty Area: Pediatric Urology
Dr. Anthony Atala is Chair of Urology, and Director, Institute for Regenerative Medicine at Wake Forest University. He is a practicing surgeon and a researcher in the area of regenerative medicine. He is Editor-in-Chief of Stem Cells-Translational Medicine and Therapeutic Advances in Urology, and serves on the editorial board of 20 journals. He has received the US Congress funded Christopher Columbus Award, World Technology Award in Medicine, Samuel Gross Prize, Barringer Medal by the AAGUS, and Gold Cystoscope award. Dr. Atala's work has been included twice in Time magazine's top 10 medical breakthroughs of the year. He was featured in U.S. News & World Report as one of 14 Pioneers of Medical Progress in the 21st Century. Ten applications of technologies developed in his laboratory have been used clinically. He is the editor of 12 books, has published over 300 journal articles, and has over 200 patents.
Gopal H. Badlani, MD
Sub-Specialty Areas: Voiding Dysfunction, Female Urology, and Endourology
Gopal H. Badlani, MD, is currently professor of urology, vice chair for clinical affairs, and director of the Urogynecology Regenerative Medicine Program at Wake Forest Baptist Medical Center in Winston-Salem, NC. Dr. Badlani was president of the New York Section of the AUA and has served on numerous AUA committees, including the Bylaws, Section Secretaries and Annual Program committees. He is the former president of the Endourological Society and the Association of Indian Urologists in North America.
Dr. Badlani serves on the National Diabetes and Digestive and Kidney Diseases Advisory Council of the National Institutes of Health and has served on the boards of the International Volunteers in Urology, the National Kidney Foundation, and the Society for Urodynamics and Female Urology, to name a few. He has held numerous editorial appointments throughout his career. He was the managing Editor of Journal of Endourology and the Journal of Videourology, and is currently editor of the AUANews.
In 2013, Dr. Badlani was one of three physicians nationwide selected to receive a Physician of the Year Award for Clinical Excellence from Castle Connolly Medical Ltd. The award recognizes physicians who exemplify excellence in clinical medical practice.
Dr. Badlani is a renowned expert in voiding dysfunction, specifically related to urinary incontinence, pelvic organ prolapse in women, male incontinence from prostate surgery and neurological disease. He has completed a number of trials for new minimally invasive treatments for benign prostate obstruction. He currently conducts research under two National Institutes of Health grants on identifying biomarkers for interstitial cystitis and using muscle precursor cells to treat incontinence in a nonhuman primate model.
Dr. Badlani completed his urological training at Long Island Jewish Medical Center in New York and a fellowship at Baylor University in 1983. He has been a member of the AUA since 1986.
John M. Barry, MD
Sub-Specialty Areas: Kidney transplantation, Surgery of Peyronie's disease and erectile dysfunction, and Prostate cancer from a patient's perspective
Dr. Barry is Professor of Surgery in the Divisions of Urology and Abdominal Organ Transplantation at the Oregon Health and Science University where he has been a faculty member since 1973. His academic administrative positions have been Director of Kidney Transplantation (1976-2009), Chief of the Division of Urology and Renal Transplantation (1980-2008), and Chief of the Division of Abdominal Organ Transplantation (2000-2002). His specialty areas are kidney transplantation, surgical diseases of the kidney, erectile dysfunction, Peyronie's disease, and prostate cancer; the last from a patient's perspective.
He has been president of the American Urological Association and the American Board of Urology.
Dr. Barry has more than 300 publications in the fields of urology and renal transplantation, and he has been a visiting professor or guest speaker nationally and internationally.
Arthur L. Burnett, MD, MBA, FACS
Sub-Specialty Areas: Sexual Medicine, Genitourinary Reconstruction, Genitourinary Oncology
Dr. Arthur (Bud) Burnett received his AB degree in Biology from Princeton University and MD and MBA degrees from Johns Hopkins University. His post-graduate training in general surgery, urology, and reconstructive urology and urodynamics was performed at the Johns Hopkins Hospital. He received an American Foundation for Urologic Disease scholarship and joined the faculty at the Johns Hopkins University School of Medicine. He is currently the Patrick C. Walsh Professor of Urology and is the Director of the Basic Science Laboratory in Neuro-urology of the James Buchanan Brady Urological Institute and Director of the Male Consultation Clinic. He is an alumni member of the Alpha Omega Alpha Honor Medical Society and Fellow of the American College of Surgeons.
Steven C. Campbell, MD, PhD
Sub-Specialty Areas: Kidney Cancer, Partial Nephrectomy, Renal Function after Kidney Cancer Surgery, Management of Small Renal Masses, Integration of Surgery and Targeted Therapies for Advanced Kidney Cancer
Dr. Campbell is Professor of Surgery, Residency Program Director, Vice Chairman of Urology, and a member of the Center for Urologic Oncology in the Glickman Urological and Kidney Institute at The Cleveland Clinic. He obtained BS, MD and PhD degrees at The University of Chicago and then did a Urology Residency at The Cleveland Clinic (1989-1995), followed by a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center (1995-1996).
Dr. Campbell's primary interests include renal cell carcinoma, bladder cancer, prostate cancer, treatment related osteoporosis, tumor angiogenesis, and urology residency training. His background also includes American Foundation for Urological Diseases (AFUD) and Kimmel Research Scholarship Awards, and he is a member of the American Board of Urology Examination Committee. He is currently Chair of the Board Exam Committee for the Society of Urologic Oncology and Secretary/Treasurer for the Society of Pelvic Surgeons. Dr. Campbell is Co-Editor of Renal Cell Carcinoma (BC Decker, 2009) and Editor of 100 Questions and Answers about Kidney Cancer (Jones and Bartlett, 2008), and was Co-Chair of the AUA Guidelines Panel: Management of the Clinical T1 Renal Mass (J. Urology, 2009). Dr. Campbell has also authored or co-authored "Malignant Renal Tumors" for Campbell/Walsh Urology for the past 3 editions (2000, 2005, and 2010).
Erik P. Castle, MD
Sub-Specialty Areas: Urologic Oncology, Minimally Invasive Surgery, Robotic Surgery, Laparoscopic Surgery
Dr. Castle is an associate professor of urology at Mayo Clinic College of Medicine and works in the Department of Urology at Mayo Clinic in Phoenix, Arizona. His surgical expertise includes:
He has performed many of these operations internationally and has participated as faculty in post-graduate courses. He is also the director of the international laparoscopic nephrectomy courses throughout Mexico on behalf of the American Urological Association and serves on the Laparoscopic, Robotic and New Technologies committee. He is fluent in Spanish and does presentations in both Spanish and English.
Dr. Castle's research interests include prostate cancer, bladder cancer and kidney cancer. His basic science research is focused on novel secondary hormonal therapies of prostate cancer and genomics of prostate and bladder cancer.
William J. Catalona, MD
Sub-Specialty Areas: Prostate Cancer, BPH
William J. Catalona, MD, Professor of Urology is the Director of the Clinical Prostate Cancer Program at Northwestern University Feinberg School of Medicine. A graduate of Yale Medical School, he trained at Yale, UCSF, NIH, and Johns Hopkins. He was the first to show that PSA could be used as a screening test for prostate cancer. His awards include the Gold Cystoscope, 1986; Hugh Hampton Young Award, 1994; Eugene Fuller Triennial Prostate Medal, 1998; The Johns Hopkins Society of Scholars, 1994; Barringer Medal, 1999; Edward L. Keyes Medal, 2003; Charles Huggins Medal, 2005; New York Academy of Medicine's Ferdinand Valentine Medal, 2007, the Ramon Guiteras Lectureship (2011). He has performed 6,000 nerve-sparing radical prostatectomies, authored more than 430 articles and books. His research interests are prostate cancer screening, treatment, and genetics. He has been principal investigator on grants from NIH, Department of Defense, American Cancer Society and Prostate Cancer Foundation.
Sam S. Chang , MD
Sub-Specialty Areas: Urologic Oncology, Bladder Cancer, Kidney Cancer, Prostate Cancer, Robotic Surgery
After receiving his AB degree from Princeton University, Dr. Chang received a full, merit based scholarship at Vanderbilt University Medical School and graduated AOA. Following residency, he completed his uro-oncology fellowship as Chief Fellow at Memorial Sloan-Kettering Cancer Center and is currently Professor of Urologic Surgery at Vanderbilt University. Focusing on urologic oncology and education, he has led efforts in integration of evidence-based medicine in clinical pathways, enhanced guidelines formulation, and improved cancer staging as chair of the AJCC GU Staging Panel. He was the vice-chair of the AUA Guidelines on Noninvasive Bladder Cancer and is currently the facilitator for the Renal Cancer Followup Guidelines. Dr. Chang has authored more than 200 original publications. For his academic efforts, he received the SUO's first-ever Distinguished Service Award, the CaPCURE Young Investigator Award, and was named a Journal of Urology's Best Reviewer. Dr. Chang was recently honored with the 2011 American Urological Association Gold Cystoscope Award.
Ralph V. Clayman, MD
Sub-Specialty Areas: Urolithiasis, Diagnosis and treatment of small renal masses, Cryoablation
Dr. Ralph V. Clayman graduated from Grinnell College and the University of California - San Diego, School of Medicine. He completed urology residency at the University of Minnesota followed by a two year American Urological Association Scholar's program at Southwestern Medical School in Dallas. In 1984 he moved to Washington University where he became Professor of Urology and Radiology. In 1990, he and his team performed the world's first laparoscopic nephrectomy, and subsequently other "firsts" in laparoscopic surgery; he holds 14 patents and has > 400 peer reviewed publications. In January 2002, he became Chair of the Department of Urology at the University of California – Irvine; within 6 years the program was ranked 18th in the country. He is a co-founder of the Endourology Society for which he serves as President (2011) and founding co-editor of the Journal of Endourology. In February 2010, he was appointed Dean of the School of Medicine at UC Irvine.
J. Quentin Clemens, MD, FACS, MSCI
Sub-Specialty Areas: Urinary Incontinence, Neurourology, Urologic Reconstruction, Overactive Bladder, Interstitial Cystitis, Prostatitis, Health Policy, Health Services Research
J. Quentin Clemens, MD, FACS, MSCI is Associate Professor of Urology and Director of the Division of Neurourology and Pelvic Reconstructive Surgery at the University of Michigan. Along with John DeLancey, he co-directs the fellowship in Female Pelvic Medicine and Reconstructive Surgery. His research interests are in the areas of epidemiology and health services research related to benign urologic diseases. He has been Principal Investigator or co-Investigator on multiple NIH-funded projects related to urinary incontinence, interstitial cystitis and chronic prostatitis, including the recently funded NIDDK MAPP research network. He is Chair of the Data and Safety Monitoring Board for the NIDDK Urinary Incontinence Treatment Network. He has also been actively involved in health policy issues with the AUA, where he was named the Gallagher Health Policy Scholar for 2008-2009. He is Chair of the AUA Quality Improvement and Patient Safety Committee, and a member of the AUA Clinical Practice Guidelines Committee and the AUA Health Policy Council.
Michael Shawn Cookson, MD, MMHC
Sub-Specialty Areas: Urologic Oncology, Bladder Cancer: Non-Muscle Invasive, Bladder Cancer: Muscle Invasive, BCG, BCG Refractory Non-Muscle Invasive Bladder Cancer, Radical Cystectomy: Open, Radical Cystectomy: Robotic, Neoadjuvant/Adjuvant Chemotherapy in Bladder Cancer, Lymphadenectomy, Urinary Diversion, Continent Urinary Diversion, Guidelines for Non-Muscle Invasive Bladder Cancer, Prostate Cancer, Prostate Cancer: Localized, Prostate Cancer: Advanced, Radical Prostatectomy: Open, Radial Prostatectomy: Robotic, Castrate Resistant Prostate Cancer, Guidelines for Localized Prostate Cancer, Guidelines for Advanced Prostate Cancer
Michael Shawn Cookson, MD, is the Patricia and Rodes Hart Professor in Urologic Surgery and the Vice Chair of Clinical Affairs in the Department of Urologic Surgery at Vanderbilt University School of Medicine. He also serves as the Director of the Fellowship Program in Urologic Oncology.
Dr. Cookson has devoted a significant protion of his career to teaching and education, and been actively invovled in the development of clinical pathways and evidence-based guidelines in urologic oncology. For more than a decade, he has been involved in the American Board of Urology (ABU) and Amerian Urological Association's (AUA) written examination. He co-founded and served chair of the Oncology Knowledge Assessment Test (OKAT) Committee for the Society of Urologic Oncology (SUO), which serves to provide education testing for fellowships in Uro-oncology across the country. He also serves as a member of the ABU Oral Board Examination Committee. He currently serves as Chairman of the AUA's Panel on Castration Resistant Prostate Cancer and has been a panel member on the AUA Guidelines for Clinically Localized Prostate Cancer. In May 2010, Dr. Cookson received the R. Michael Rodriguez Award for Excellence in Teaching at Vanderbilt and was awarded the Distinguished Service Award in May 2012 by the SUO. Dr Cookson has authored or co-authored more than 200 original publications. His clinical research has led to an improved understanding of the clinical and surgical management of prostate and bladder cancer. He is an expert in both open and robotic-assisted laparoscopic surgical techinques and in the techinques of urinary diversion and its impact on quality of life.
Robert C. Flanigan, MD
Sub-Specialty Areas: Renal, Prostate, and Bladder Cancer
Robert C. Flanigan, M.D. was born in Lima, Ohio on May 2, 1946. He attended the College of Wooster and Case Western Reserve University (CWRU) Medical School before completing his residencies in urology and general surgery at CWRU Affiliated Hospitals. He is board certified in both urology and surgery. After residency, Bob served in the U.S. Air Force for two years and was awarded the Air Force Commendation Medal. He then began his academic career at the University of Kentucky where he was promoted to Associate Professor, and served as Chief of Urology at the Lexington VA Hospital.
In 1986, Bob accepted the position of Professor and Chairperson of the Department of Urology at Loyola University Medical Center (Stritch School of Medicine). In 1994, he became the first Albert J. Speh, Jr. and Claire R. Speh Professor of Urology at Loyola.
Bob has been very involved in basic and clinical research throughout his career. He has contributed over 290 publications to the medical literature. In addition, he recently was elected Secretary of the American Urological Association, he has served as President of the American Board of Urology, President of the Society of Urologic Oncology, President of the North Central Section of the AUA, President of the Society of University Urologists, and was founder and first President of the Society of Urologic Chairpersons and Program Directors. He also serves as a Governor of the American College of Surgeons and as a member of the Executive Committee of the Board of Director's of the American Board of Medical Specialties. He is a member of the American Association of Genitourinary Surgeons and the Clinical Society of Genitourinary Surgeons.
Bob's primarily research interests have been in the areas of renal, prostate, and bladder cancer. He has served as the Principal Investigator for Loyola of the NIH funded Urologic Cancer Outreach Program from 1988-to present.
Pat Fox Fulgham, MD, DABU, FACS
Sub-Specialty Areas: Urologic Oncology, Urologic Ultrasound, Robot-assisted Laparoscopic Surgery, Imaging and Radiation Safety
Dr. Pat Fulgham is a board certified urologist who has been in private practice at Texas Health Presbyterian Hospital of Dallas since 1987. He is a Texas A & M graduate and received his medical training at the University of Texas Southwestern Medical School. He is chairman of the AUA Urologic Diagnostic & Therapeutic Imaging Committee Dr. Fulgham has shared his expertise in imaging by serving on the American College of Radiology Appropriateness Criteria Expert Panel on Urology and on the Clinical Standards Committee for the American Institute of Ultrasound in Medicine. He was guest editor for Urology Clinics of North America on the topic of Urologic Imaging, published in 2006. Dr Fulgham has been honored by the AUA for his work in training urologic ultrasound with the presentation of the Distinguished Service Award in 2008. He co-authored the chapter on imaging for Campbell-Walsh Urology, 10th Edition. Dr. Fulgham has conducted courses on urologic ultrasound for the AUA since 1992 and has served as the course director for the Hands-On Ultrasound course since 2002.
Howard B. Goldman, MD FACS
Sub-Specialty Areas: Female Urology, Neurourology, Female Pelvic Medicine and Reconstructive Surgery, Incontinence, Overactive Bladder, Prolapse Repair, Management of Complications of Incontinence and Prolapse Surgery, Urethral Diverticula, Urogenital Anatomy
Dr. Howard B. Goldman is fellowship trained and board certified in the subspecialty of female pelvic medicine and reconstructive surgery. He is a professor on the faculty of the Cleveland Clinic Lerner College of Medicine and is also an expert on quality and patient safety and is the Institute Vice Chairman for Quality at the Glickman Urologic Institute. He has a joint appointment in the departments of urology and obstetrics and gynecology, is actively involved in the training of fellows and residents and is the past Fellowship director for Female Pelvic Medicine and Reconstructive Surgery in the Department of Urology at the Cleveland Clinic. His interests are in the medical and surgical treatment of urinary incontinence and other types of voiding dysfunction, neuromodulation, prolapse repair, complex redo female urologic surgery and fistula repair. He has authored over 200 articles and book chapters, is the editor of three textbooks, has been a visiting professor in the United States and abroad having given numerous invited lectures. He is on the editorial board of a number of journals and is currently one of the Assistant Editors of the Journal of Urology. He has served on a number of guidelines and best practice statement panels for the AUA and international organizations. He has also been involved in the development of innovative techniques for the treatment of urinary incontinence and prolapse and received a number of awards for his work.
Waleed Hassen, MD
Sub-Specialty Areas: Urologic Oncology and Minimally Invasive and Robotic Surgery
Waleed A. Hassen MD is the Chairman of Urology at Tawam Hospital in affiliation with Johns Hopkins as well as an Assistant Professor of Urology at Johns Hopkins University, School of Medicine. He is an expert in urologic oncology and minimally invasive and robotic surgery. Dr. Hassen received his MD from Eastern Virginia Medical School and trained at the Mount Sinai School of Medicine. He subsequently completed a fellowship Urologic Oncology and Minimally invasive fellowship at Memorial Sloan Kettering Cancer Center. He is one of a handful of urologists worldwide who are formally trained in oncology and minimally invasive surgery. He is an editorial reviewer for numerous scientific journals and a member of many urological and oncologic societies. Dr. Hassen is currently the chairperson of the NCCN's Middle East and North Africa panel for the modification of prostate cancer guidelines. Prior to his arrival in the UAE, Dr. Hassen was Director of Urologic Oncology at the Mount Sinai School of Medicine and remains as an Adjunct Professor there.
Gerald H. Jordan, MD, FACS, FAAP(Hon.), FRCS(Hon.)
Sub-Specialty Areas: Adult and Pediatric Genitourinary Reconstructive Surgery, Erectile Dysfunction, Peyronie's Disease
Gerald H. Jordan, MD received a Bachelor of Science degree in Aeronautical Engineering, with merit, at the United States Naval Academy in 1966, and in 1967 he entered the United States Navy and was designated a Naval Aviator in December 1967. Dr. Jordan earned his medical degree from the University of Texas in 1977 after completing the Bachelor's program in Pre-Medicine at Cal Western in 1973. He completed his internship and residency at the Naval Regional Medical Center in Portsmouth, VA, and was trained as a Designated Flight Surgeon through the United States Air Force Flight Surgeons' Course in 1977.
Dr. Jordan's practice was limited almost exclusively to adult and pediatric genitourinary reconstructive surgery. Board certified in Urology, he is a Fellow of the American College of Surgeons and is an Honorary Member of the American Academy of Pediatrics and The Royal College of Surgeons-England. Dr. Jordan served as Professor of Urology and recently served as the Director of the Adult and Pediatric Genitourinary Reconstructive Fellowship Program at the Eastern Virginia Medical School. He has wide and varied academic interests and is an innovative leader in the field of genitourinary reconstructive surgery. He is keenly motivated in the area of investigation and has made notable contributions to Urologic literature. Dr. Jordan also participates in numerous national and international medical conferences and serves as a visiting professor at many centers throughout the world.
Ashish M. Kamat, MD
Sub-Specialty Areas: Urologic Oncology, Bladder Cancer, Prostate Cancer, Robotic Surgery
Dr. Ashish M. Kamat is a Professor and Attending Surgeon in the Department of Urology and the Director of the Urologic Oncology Fellowship Program at M.D. Anderson Cancer Center in Houston, TX. Dr. Kamat is an active member of the urologic community, and a graduate of the AUA Leadership Program. He obtained a HSC degree in Biologic Sciences from Jai Hind College in 1988 and an MD (MBBS) degree from Seth G.S. Medical College, Bombay, India in 1994. Dr. Kamat subsequently completed his urology residency at West Virginia University in 2001 and completed a fellowship in Urologic Oncology at MD Anderson Cancer Center in 2003.
Dr. Kamat is recognized internationally as an outstanding urologic oncology surgeon with an emphasis on bladder cancer, organ sparing and minimally invasive techniques and had demonstrated surgeries and lectured on this subject globally.
Dr. Kamat's research focuses on efforts to develop novel therapies, and identify predictors of response to therapy (e.g. intravesical immunotherapy) as a first step towards personalized cancer therapeutics. His approach encompasses novel use of existing agents, the identification or novel targets and therapies, or a combination of these strategies; and this, coupled with Dr. Kamat's expertise in the clinical care of bladder cancer patients, provides a pathway for bench to clinic for active agents in this arena. His clinical research is geared towards developing risk assessment and response to therapy prediction models incorporating tissue, serum, and urinary markers (especially as pertains to their role in personalized cancer therapeutics). Dr. Kamat has initiated, led, and been active in several large studies including multinational trials in bladder cancer; these findings have been published in high impact journals. Dr. Kamat is a Co - Principal Investigator (PI) on the MD Anderson Genitourinary (GU) Specialized Programs of Research Excellence (SPORE) in the Bladder Cancer Project.
Dr. Kamat has authored numerous editorials, book chapters, and over 185 publications in peer reviewed journals, and serves on the editorial board of high ranked journals. Additionally, Dr. Kamat is on grant review panels of national and international study sections; he is also the co-chair of the International Bladder Cancer Network (IBCN), and serves in an advisory capacity to various organizations, such as the National Cancer Institute's (NCI) Bladder Cancer Task Force (BCTF).
Dr. Kamat is an exceptional educator and has been essential to the growth of the Urologic Oncology Fellowship, as its Program Director, forming it into a premier program in the US. For his accomplishments, Dr. Kamat has been nominated twice for the Robert M. Chamberlain Distinguished Mentor Award. Dr. Kamat is also the Co-President of the International Bladder Cancer Network, Chair of the Bladder Cancer Think Tank, actively participates in various Global Program efforts, serves on the boards of regional and national societies for Urology & Urologic Oncology (e.g. SCS – AUA, SUO-CTC) and patient advocacy groups (MD Anderson Bladder Support Group, Bladder Cancer Advocacy Network).
Dr. Kamat is a member of the American Urological Association (AUA) and served on the AUA Practice Guidelines Committee and Young Urologist Committee. Currently, Dr. Kamat is on the AUA South Central Section Board of Directors and serves as the AUA State Representative for Texas. Furthermore, Dr. Kamat is cited in the 'Who's Who in Medicine' and the 'Best Doctors in America' and has won the "Compassionate Doctor Award" from patient groups. Dr. Kamat is committed to urologic education and has been invited to deliver Plenary Talks, Keynote Talks (both nationally and internationally) and participating as a speaker and as course faculty for the AUA and other organizations – domestic and world-wide.
Jihad H. Kaouk, MD
Sub-Specialty Areas: Robotic and Laparoscopic Surgery, Management of Renal Masses, Robotic Radical Cy stectomy, Robotic Radical Prostatectomy, Kidney Tumor Ablation Cryoablation and RFA
Dr. Jihad Kaouk is an American Board certified Urologist who helps patients at the Cleveland Clinic Glickman Urological and Kidney Institute as the Director of the Center of Advanced Laparoscopic and Robotic Surgery. He also serves as a Professor of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Complementing his role as Director, Jihad Kaouk, MD, holds the position of Institute Vice- Chair for Surgical Innovations and the chair holder for the Zegarac-Pollock Endowed Chair in laparoscopic and robotic surgery at the Glickman Urological and Kidney Institute. Dr. Jihad Kaouk is listed in Who's who in America and Top Docs in America and recently listed on Microsoft academic search as the top 10 authors in urology worldwide.
As such, he has performed groundbreaking surgical procedures, including the first Robotic single port surgery through the belly button in 2008 and the first completely transvaginal kidney removal in 2009. Dr. Kaouk has one of the largest experiences in robotic surgery in the country especially if robotic radical prostatectomy and robotic partial nephrectomy. Dr. Kaouk has multiple pending or issued USA patents for medical devices and was awarded "Cleveland Clinic innovator" for years 2006, 2011, and 2013.
Moreover, Jihad Kaouk, MD, engages in the academic progress of his field in his role as the Associate Editor of Urology journal, and as a Section Editor for The Journal of robotic surgery and the Arab Journal of Urology. He also acts as an Ad Hoc Reviewer for Numerous peer-reviewed publications. Since 2005, Dr. Kaouk has served on committees at the national and local levels. From 2005 to 2008, he belonged to the American Urological Association's Urologic Diagnostic and Therapeutic Imaging Task Force, and from 2006 to 2010 he was on the Guide Panel of the Management of Incidentally Discovered Renal Masses committee.
Dr. Jihad Kaouk have lectured in more than 130 scientific meetings, chaired more than 20 urologic meeting and performed live surgery demonstrations in 18 medical centers worldwide. Dr. Jihad Kaouk have more than 260 peer reviewed scientific publication, 18 book chapters and hundreds of scientific abstracts and surgical illustration movies. Dr. Jihad Kaouk received 32 honors and awards for his work in the professional field.
Presently, Dr. Kaouk holds membership with the American Urological Association, the Endourological Society, and American College of Surgeons, Society of Robotic Surgery, and the Lebanese Order of Physicians.
Larry I. Lipshultz, MD
Sub-Specialty Areas: Male Infertility, Microsurgery in the Male, Erectile Dysfunction, Male Hormone Replacement Therapy, Genetic Causes of Male Infertility
Larry I. Lipshultz, MD, is Professor of Urology and Chief of the Scott Department of Urology's Division of Male Reproductive Medicine and Surgery at Baylor College of Medicine in Houston, Texas. Dr. Lipshultz, who holds the Smith Chair in Reproductive Medicine, is a well-known authority on abnormalities of male reproduction, erectile dysfunction, and male hormone production.. He received his medical training at the University of Pennsylvania and after further postgraduate training was the first AUA research scholar. He is a member of the GU Surgeons, a founder of the Society for the Study of Male Reproduction, and is the second urologist elected President of the American Society for Reproductive Medicine (ASRM). He has been an active member of the AUA throughout his career and in 2005 received the Hugh Hampton Young Award. Among many other activities, he has served on the FDA Advisory Committee for Reproductive Health Drugs. In 2010 the AUA named him "one of the most respected surgeon scientists and mentors in Urology," and in 2011 he received the American Society for Reproductive Medicine Service Award. He has published more than 200 journal articles, serves on the editorial boards of several major journals, and edited two widely used comprehensive text books - Urology and the Primary Care Practitioner, (3rd Edition Dec. 2008) and Infertility in the Male,(4th Edition Nov. 2009). He frequently is invited to lecture in the US and abroad, and he is listed routinely in Best Doctors in America and Castle Connolly's America's Top Doctors.
Tom F. Lue, MD
Sub-Specialty Areas: Male Sexual Dysfunction, Priapism, Peyronie's Disease
Dr. Tom F. Lue graduated with highest honors from the Kaohsiung Medical College in Taiwan in 1972. He is Professor and Vice-Chair of Urology at UCSF. He also is Director of the Knuppe Molecular Urology Laboratory, a recipient of NIH MERIT Award for his translational research in penile physiology and erectile dysfunction. His team discovered the anatomical mechanism of venous compression during penile erection, published the first article implicating TGF beta in the formation of Peyronie's plaque, and developed the animal models for the study of Peyronie's disease and stress urinary incontinence. His clinical research "firsts" include authorship of the New England Journal of Medicine paper describing the landmark clinical trial introducing Sildenafil (Viagra®) for erectile dysfunction, and the development of four diagnostic tests for erectile dysfunction: the penile injection and stimulation test, the duplex ultrasound test for penile arterial flow, pharmacologic cavernosography for venous leakage, and the use of duplex ultrasound to diagnose priapism. He also developed seven new surgical procedures for Peyronie's disease, priapism and erectile dysfunction. He has been the recipient of the American Urological Association's Gold Cystoscope Award and the American Foundation of Urological diseases' Most Innovative Researcher Award. He Chaired the International Consultation on Sexual Medicine held in Paris in July 2003 serving as lead author of its published proceedings. He was the honorary president of the same meeting in Paris in July, 2009.
Dr. Lue's current basic science research projects involve the development of animal models for research in erectile dysfunction due to hormone deficiency, cavernous nerve injury, diabetes mellitus and hyperlipidemia. Regarding Peyronie's disease, he is currently testing the hypothesis that prolonged inflammation/autoimmune reaction is involved in the pathogenesis of Peyronie's disease. His lab also has 10 years of experience in basic cell biology research of mesenchymal stem cells [MSC]. His lab is one of the first to show evidence that MSCs are vascular stem cells existing in various tissues and paracrine effect may be involved in the action of implanted MSC in addition to cellular differentiation. Using animal models, Dr. Lue also is exploring the feasibility of using adipose tissue derived adult stem cells as a source of stem cells for the treatment of stress urinary incontinence, neurogenic impotence and functional recovery after spinal cord injury. The application of MSC in erectile dysfunction is scheduled for clinical trial soon.
Besides being listed in The Best Doctors in America and America's Top Doctors for many years, he was named one of the 8 top doctors for men by Men's Health Magazine in 2003. He has published more than 360 peer reviewed articles and more than 100 book chapters. His research team has trained more than 70 postgraduate doctors and most of them are continuing research career in academic institutions in many countries.
John H. Lynch, MD
Sub-Specialty Areas: Urologic Oncology, BPH
John H. Lynch, MD, is a professor and chair of the Department of Urology at Georgetown University Hospital in Washington, DC, and has served as program director there for the past 19 years. Dr. Lynch received his medical degree from the Georgetown University School of Medicine, where he also completed his urology residency. In 2009, Dr. Lynch was inducted into Georgetown University Medical Center's MAGIS Society of Master Teachers. He has authored more than 125 publications and abstracts and has delivered more than 150 presentations in the area of urologic oncology.
Dr. Lynch previously served on the AUA Practice Guidelines Committee and the Education Council and helped develop the AUA online Ethics Curriculum. He is also a fellow in the American College of Surgeons (ACS) and serves on the Credentials Committee of the Washington Chapter of the ACS. Dr. Lynch has served numerous roles in local and regional urological or medical organizations, including the Mid-Atlantic Section of the AUA. He is also a member of the Society of Urologic Oncology, the Society of University Urologists and serves on the Executive Committee of the Society of Urology Chairs and Program Directors. Dr. Lynch has been a member of the AUA since 1981.
Elspeth M. McDougall, MD, FRCSC, MHPE
Sub-Specialty Areas: Minimally Invasive Surgery of the Kidney/Ureter, Stone Disease, Surgical Education
Dr. McDougall joined the University of California, Irvine, Department of Urology faculty in 2002 to continue her clinical and research work in minimally invasive urologic surgery and assist in the development of a minimally invasive surgery education center. She is internationally recognized for her laboratory and clinical research in urologic laparoscopic surgery and for teaching courses on fundamental and advanced endourological and laparoscopic techniques.
Dr. McDougall completed her medical and residency training at the University of Calgary and the University of Ottawa in Canada, and then undertook a fellowship in endourology and extracorporeal shock wave lithotripsy (ESWL) with Dr. Clayman at Washington University School of Medicine. She joined the faculty at Washington University Medical School in 1991, where she spent nine years in academic urology. Subsequently, she developed the Endourology/Laparoscopic Urology Program at Vanderbilt University in Nashville, Tennessee, during her tenure there as Professor of Urologic Surgery. She is a Fellow of the Royal College of Surgeons of Canada (Urology) and certified with the American Board of Urology. Dr. McDougall has published more than 230 peer-reviewed journal articles and numerous book chapters. She is the co-editor of two textbooks on laparoscopic surgery. In 2008, Dr. McDougall successfully completed a Masters in Health Profession Education from the University of Chicago at Illinois.
Dr. McDougall has been chairperson of the AUA Laparoscopy Committee and coordinated the Ad Hoc Surgical Simulation Group with the American Urological Association. She has now assumed the position as Chair of the American Urological Association Office of Education. In this role she oversees all aspects of the educational programs and activities of the AUA. She is on the editorial boards of the Journal of Endourology and the Journal of the Society of Laparoendoscopic Surgeons. She is Past President of the Society of Laparoendoscopic Surgeons and was awarded the Excel Award by this multidisciplinary surgical society in 2007. She is a member of the World Congress of Endourology's Scientific Meeting Advisory Committee. She is an elected member to the prestigious American Association of Genitourinary Surgeons and was a junior council member for that organization from 2007 – 2009.
Dr. McDougall is Director of the Minimally Invasive Surgery Education Center at UCI and has developed the ongoing, five-day mini-residency training program in minimally invasive urologic surgery for post-graduate urologists. She is the Program Director of the Urology Residency Training program at UC Irvine. She is also Associate Dean of Simulation and Continuing Medical Education at the University of California, Irvine.
Mani Menon, MD
Sub-Specialty Areas: Oncology and Minimally Invasive Surgery
Mani Menon, MD, is chairman of the Department of Urology at the Henry Ford Health System, the Rajendra and Padma Vattikuti Distinguished Chair in Oncology and Director of the Vattikuti Urology Institute. Dr. Menon is Clinical Professor of Urology at Case School of Medicine, University of Toledo, and New York University.
Dr. Menon has published more than 300 papers, primarily in the field of robotic surgery, renal transplantation and urolithiasis. His work has appeared in the major urological journals as well as in the Journal of Clinical Investigation, the Journal of Biological Chemistry, the American Journal of Physiology, Proceedings of the National Academy and the New England Journal of Medicine. He is a past member of the National Kidney and Urological Disease Advisory Board and a Trustee of the American Board of Urology. Dr. Menon is profiled in the Best Doctors of America and the International Who's Who in Biology and Medicine. He has been a visiting professor at various institutions not only inside the USA, but also all across the globe, where he has lectured and performed robotic surgery.
Manoj Monga, MD, FACS
Sub-Specialty Areas: Endourology and Stone Disease
Dr. Monga is the Director of the Stevan Streem Center for Endourology & Stone Disease at the Glickman Urological & Kidney Institute of the Cleveland Clinic. Prior to this he was the Joseph Sorkness Professor and Vice-Chair of Urology at the University of Minnesota. After graduating from the Chicago Medical School, he completed his residency at Tulane University. He specializes in Endourology and Stone Disease. He was awarded the Endourology Society "Arthur Smith Young Innovators' Award" in 2007, and has over 250 peer-reviewed publications. His research has focused on the evaluation and design of medical devices related to endourology. He is a Section Editor for the Journal of Endourology. He serves on the Board of Directors of the Endourology Society.
Dr. Monga is a member of the American Board of Urology Exam Committee. He serves on the American Urological Association Quality Improvement and Patient Safety Committee. He is the Past-President of the Minnesota Urological Society and Past-President of the Engineering & Urology Society.
John P. Mulhall, MD
Sub-Specialty Areas: Erectile Dysfunction, Penile Rehabilitation, Peyronie's Disease, Sexual Dysfunction, Infertility
John P. Mulhall, MD, a native of Dublin, Ireland is the Director of the Male Sexual & Reproductive Medicine Program, and Director of the Sexual Medicine Research Laboratory at Memorial Sloan Kettering Cancer Center in New York City. He holds an adjunct position as professor of urology in the Department of Urology at Weill Cornell Medical College. He completed his urology residency training at University of Connecticut Health Center, and his Sexual/Reproductive Medicine & Surgery Fellowship training at Boston University Medical Center.
Dr. Mulhall is heavily involved in clinical and laboratory research activities. He has spent more than a decade studying radical prostatectomy associated sexual dysfunctions and Peyronie's disease in laboratory and in clinical studies. Dr Mulhall's basic research interests include defining the pathobiology of Peyronie's disease fibroblasts and erectile function preservation in cavernous nerve injury models. His clinical research is currently focused on predictors of post-prostatectomy erectile function recovery, pelvic radiation associated ED, quality of life in prostate cancer patients as it pertains to sexual health, penile structure imaging, as well as the design and conduct of drug trials in sexual medicine.
Dr. Mulhall has 200 papers published in peer-reviewed journals, and has published the books, Contemporary Management of Urologic Emergencies (1999), Sexual Function In The Prostate Cancer Patient (2009) and recently published a book for men with prostate cancer titled Saving Your Sex Life: A Guide For Men With Prostate Cancer (2008). The textbook Cancer & Sexual Health, which he edited, was published in the first quarter of 2011 and the textbook Fertility Preservation In The Male Cancer Patient, which he also edited will be available at the end of 2011. He has contributed in excess of 50 book chapters. He was editor-in-chief of the review journal Current Sexual Health Reports until 2007. He is also an Associate Editor for The Journal of Sexual Medicine, and has served on the editorial board of The Journal of Urology and Reviews in Urology.
Dr. Mulhall serves on the Board of Directors of the Sexual Medicine Society of North America (SMSNA) and is currently its President. He is Co-Chair of the standards committee of the International Society for Sexual Medicine (ISSM) and co-chair of the scientific program committee of the 2012 joint meeting of the SMSNA/ISSM. He is also the vice-chair of the Core Curriculum Committee of the AUA.
Dr. Mulhall is the recipient of numerous awards, including a Career Development Award from the United States Veterans Administration (1998), the Robert P. Nelson Award from the Sexual Medicine Society of North America (2001), a Young Investigator Award from ISSM (2000) and the Jean Francois Ginestié Award (2002) from ISSM for basic science research. In 2005 he was honored by the American Urological Association with the prestigious Gold Cystoscope Award awarded annually to a single young leader in urology for their contribution to the field.
Stephen Y. Nakada, MD
Sub-Specialty Areas: Endourology, Stone Disease: Surgical and Medical Management, Laparoscopy, and Renal Ablation
Stephen Y. Nakada, MD, the Uehling Professor and Chairman of the Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Dr. Nakada received his undergraduate degree from the Dartmouth College in 1984 and medical degree from the University of Rochester School of Medicine and Denistry in 1988. He completed residencey training at Strong Memorial Hospital in Rochester, New York in 1994. Dr. Nakada completed his Endourology Fellowship at Barnes Hospital in St. Louis, Missouri and subsequently joined the faculty at the University of Wisconsin as an Assistant Professor in 1995. In 2001, Dr. Nakada was named the Chairman of Urology and the first David T. Uehling Professor of Urology at the University of Wisconsin. Dr. Nakada has published over 175 peer-reviewed articles, edited four textbooks, and authored over 50 book chapters, primarily focusing on endourology and laparoscopy. In 2004, he received the AUA Gold Cystoscope Award. Dr. Nakada is an Associate Editor for Urology, and serves on the editorial boards of the Journal of Endourology and Urology Times. Dr. Nakada is a member of the AUA Board of Directors and is Secretary-General of the Endourology Society. He is also a member of the American College of Surgeons and the American Association of Genitourinary Surgeons, among other societies.
Victor Nitti, MD
Sub-Specialty Areas: Female Pelvic Medicine and Reconstructive Surgery, Voiding Dysfunction and Incontinence, and Neurourology
Victor Nitti, MD, is Professor of Urology and Obstetrics and Gynecology and the Vice Chairman of the Department of Urology at NYU Langone Medical Center. He is also the head of Female Pelvic Medicine and Reconstructive Surgery and is the fellowship director for that program. He is a graduate of the University of Medicine and Dentistry of New Jersey and did his urology residency at SUNY Downstate. He completed a fellowship in female urology, neurourology and reconstructive urology at UCLA in 1992.
Dr. Nitti is a Fellow of the American College of Surgeons and the American Board of Urology and a member of the American Urological Association, the Society for Urodynamics and Female Urology (SUFU), the International Continence Society and the first through fifth International Consultations on Incontinence. He served as President of the Society for Urodynamics and Female Urology from 2010-2012. Dr. Nitti is on the editorial boards of Neurourology and Urodynamics, the Journal of Female Pelvic Medicine and Reconstructive Surgery, International Urogynecology Journal, and Reviews in Urology.
Dipen Parekh, MD
Sub-Specialty Areas: Urologic Oncology and Robotic Surgery
Dr. Dipen J Parekh received his undergraduate education from Mumbai, India and his MD degree from Poona University. He then pursued a residency in General Surgery and Urology from Mumbai University, India. He was awarded the Rotary International Ambassadorial Scholarship that enabled him to pursue further training in the United States. After a Residency in Urology at Vanderbilt University Medical Center, he completed a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center. He is the first holder of the Doctors Hospital at Renaissance Distinguished University Endowed Chair in Urology. He currently serves as Chief of the Division of Urologic Oncology, Director of Fellowship in Urologic Oncology and Director of Robotic Surgery in the Department of Urology at the University of Texas Health Science Center at San Antonio. He serves as the Principal Investigator in a NCI sponsored RO1 grant for a multiinstitutional randomized clinical trial comparing open and robotic cystectomy for bladder cancer. Dr. Parekh has published several scientific papers,abstracts and book chapters in Urology.Dr.Parekh was recently invited to serve as an Assistant Editor for the Journal of Urology, the pre-eminent urology journal globally.
Margaret S. Pearle, MD, PhD
Sub-Specialty Areas: Medical and Surgical Management of Kidney Stones
Dr. Pearle attended the University of Chicago where she received her BA in Biology, PhD in Biochemistry and MD degrees. She completed her Urology residency at Northwestern University and fellowship in Endourology and Minimally Invasive Surgery at Washington University with Dr. Ralph Clayman.
Dr. Pearle is currently Professor and Vice-Chair of Urology, Professor of Internal Medicine and holder of the Ralph C. Smith Distinguished Chair in Urologic Education at UT Southwestern Medical Center. She served on the AUA Nephrolithiasis Clinical Guidelines Panel for Staghorn Calculi and Ureteral Calculi and will chair the Panel on Medical Management of Urolithiasis. In 2003, she received the AUA Gold Cystoscope Award and in 2007 was elected to the American Association of Genitourinary Surgeons (AAGUS). She is president-elect of the American Board of Urology Board of Trustees and serves on the Urology Residency Review Committee of the ACGME. She currently serves on the Board of Directors of the Endourological Society.
Glenn M. Preminger, MD
Sub-Specialty Areas: Minimally invasive management of urinary tract stones including shock wave lithotripsy, percutaneous and ureteroscopic stone removal, Comprehensive metabolic evaluation and preventative medical treatment of nephrolithiasis
Glenn M. Preminger, MD, is the James Glenn Professor and Chief of Urology and Director of the Comprehensive Kidney Stone Center at Duke University Medical Center.
His clinical interests include the minimally invasive management of urinary tract stones including shock wave lithotripsy, percutaneous and ureteroscopic stone removal. In addition, he coordinates comprehensive metabolic evaluation and preventative medical treatment of nephrolithiasis.
He has had extensive experience in the development of endoscopic instrumentation for minimally invasive urologic procedures and holds eight patents in shock wave lithotripsy design. Dr. Preminger has published more than 350 manuscripts, 100 book chapters and 9 books, as well as 30 videotapes that review complex endoscopic techniques.
Dr. Preminger served as the Chair of the American Urological Association Office of Education from 2006 – 2009. He was responsible for the quality and medical accuracy of the content of all educational course offerings of the 14,500 member Association.
Claus G. Roehrborn, MD
Sub-Specialty Areas: BPH, Voiding Dysfunction, Prostate Cancer
Claus G. Roehrborn, MD, joined the urology faculty at The University of Texas Southwestern Medical Center in 1992 and is currently Professor and Chairman of the Department of Urology. Dr. Roehrborn's research interests are in the areas of benign and malignant prostate diseases, including medical and minimally invasive therapies for BPH, and markers for prostate cancer. His basic, translational and clinical research has yielded over 300 peer-reviewed publications, more than 30 book chapters, and numerous other contributions to the literature. He serves on the editorial board of many peer-reviewed journals, is associate editor of Urology, and coeditor of the comprehensive and authoritative Textbook of BPH. At present, Dr. Roehrborn continues to be involved in virtually all aspects of BPH research as well as translational and clinical research in prostatitis and prostate cancer.
Anthony J. Schaeffer, MD
Sub-Specialty Areas: UTI, Male Incontinence, Pelvic Pain
Anthony J. Schaeffer, MD is Professor and Chairman of Urology at Northwestern University's Feinberg School of Medicine. He has made major contributions to urologic research and has been a strong advocate of physician-scientists and their needs. He's had continuous NIH funding for 30 years and received the distinguished MERIT Award from 1996-2004. He served on the NIDDK Advisory Council from 2006-2010, chaired the AUA's Research Council from 2003-2010, and is an Associate Editor for Journal of Urology. He received the AUA's Eugene Fuller Triennial Prostate Award in 2004, the Distinguished Service Award in 2010, and the Urology Care Foundation Distinguished Scholar Alumni Award in 2011. He has published extensively on UTI, inflammation and incontinence and developed and performed innovative techniques for incontinence in men and women, including the urethral sling procedure for postprostatectomy incontinence. He is a graduate of Northwestern University Medical School and the Stanford University urological residency program.
Linda M. Dairiki Shortliffe, MD
Sub-Specialty Areas: Pediatric Urology, Pediatric Urinary Tract Infections, Resistance in UTI, Pediatric Urological Imaging, Undescended Testes, Radiation Exposure in Urological Imaging, Diagnosing Hydronephrosis
Linda. M. Dairiki Shortliffe is the Stanley McCormick Memorial Professor (tenured) and was Chair of the Department of Urology at Stanford University School of Medicine from 1995-2011. She was founding Chief of Pediatric Urology at Stanford Medical Center and Packard Children's Hospital at Stanford from 1988-2012. She received her AB cum laude in History and Science from Harvard College and her MD degree from Stanford University. She started the first pediatric urological training program at Stanford Medical Center. She was the William and Flora Hewlett Foundation Fellow at the Radcliffe Institute for Advanced Study at Harvard University and is a Stanford Faculty Fellow at the Clayman Center for Gender at Stanford University. She chaired the Bladder Research Program Review for the NIH: Overcoming Bladder Disease: a Strategic Plan for Research. She was past President of the American Board of Urology, Society for University Urologists, and Society of University Chairs and Program Directors, and Chair of the Section of Urology of the American Academy of Pediatrics. She was a featured physician in the National Library of Medicine Exhibit "Changing the Face of Medicine."
Chandru P. Sundaram, MD
Sub-Specialty Areas: Laparoscopic and Robotic Surgery of the Kidney and Adrenal, Robotic Surgical Training, and Residency Training
Dr. Sundaram is professor of urology at Indiana University School of Medicine. He directs the residency program and the fellowship in minimally invasive surgery. He has over 100 peer-reviewed publications and is involved in several professional organizations including the American Urological Association and the Endourological Society. He is the president elect of the North Central Section of the AUA in 2011-12. As the chair of the Laparoscopic Robotic and New Surgical Technology Committee of the AUA, he edited the online course in Robotic Surgery, and the Robotic Surgery Credentialing guidelines. He also co-directed the establishment of Videourology, the only peer-reviewed video journal in urology. He is the co-section editor of Videourology and, as assistant editor is on the Editorial Board of the Journal of Endourology.
Ian Murchie Thompson, Jr., MD
Sub-Specialty Areas: Urologic Oncology with a focus on the Research, Prevention & Treatment of Prostate Cancer
Dr. Ian Thompson received his undergraduate degree from West Point and his MD degree from Tulane University. After residency training in Urologic Surgery in San Antonio, he completed a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center in New York. He is Director of the Cancer Therapy & Research Center and a Professor in the Department of Urology at the University of Texas Health Science Center at San Antonio. Dr. Thompson has published over 500 scientific papers, several dozen book chapters, and has edited four textbooks in medicine. He serves as Chairman of the Prostate Cancer Panel of the American Urological Association, Past Chair of the Residency Review Committee for Urology, serves as Chair of the Early Detection Research Network of the National Cancer Institute, and served as President of the Society of Urologic Oncology. Dr. Thompson is the Principal Investigator of the San Antonio center for Biomarkers Of Risk of prostate cancer (SABOR), one of the Early Detection Research Network's Clinical and Epidemiologic Validation Centers that follows a 4,500-subject cohort for the discovery and validation of new biomarkers for prostate cancer. He was the clinical coordinator of the Prostate Cancer Prevention Trial, an 18,882-subject, 10-year study by the National Cancer Institute and is co-PI of SELECT. His primary research interest is in the early detection and prevention of cancers of the genitourinary tract.
J. Brantley Thrasher, MD, FACS
Sub-Specialty Areas: Urologic Oncology, (Prostate cancer)
Dr. J. Brantley Thrasher is Professor and the William L. Valk Chair, Department of Urology and the Co-Director of Operative Services at the University of Kansas Medical Center in Kansas City, Kansas. A native of South Carolina, he completed his Medical Degree at the Medical University of South Carolina in Charleston, South Carolina, an internship at Walter Reed Army Medical Center in Washington, D.C., and his urology residency at Fitzsimons Army Medical Center in Aurora, Colorado. He subsequently completed a urologic oncology fellowship at Duke University Medical Center. He served for three years as Program Director for the Urology Residency Program at Madigan Army Medical Center in Tacoma, Washington, and after completing his military obligation, he was appointed to his present position in 1998.
In addition to giving over 300 presentations at local, national, and international meetings, he has written over 150 manuscripts, book chapters, and monographs in the field of urology. He has been a Visiting Professor at 24 institutions and serves as a reviewer for 6 journals. Dr. Thrasher's basic science research interest is in the area of prostate cancer and he is currently a co-investigator or consultant in NIH, Center for Disease Control, and Department of Defense funded research. His clinical research interests are in the area of prostate, bladder, and renal cancer, as well as reconstruction.
Karim Touijer, MD
Sub-Specialty Areas: Genito-Urinary Oncology, Minimally Invasive and Robotic Surgery, Health Outcomes and Quality of Care in Surgery
Karim Touijer is an Attending Surgeon at Memorial Sloan-Kettering Cancer and Associate Professor of Urology at The Weill Medical College of Cornell University in New York. Dr. Touijer is an expert in the use of advanced laparoscopic /robotic surgical techniques to treat patients with genito-urinary cancers (prostate, kidney, bladder, testis and adrenal cancers). He teaches advanced laparoscopic urologic oncology at the European Association of Urology, the American Urological Association Annual Meetings and the European Institute of Telemedicine.
Dr. Touijer's research focuses on the development of innovative minimally invasive techniques such as laparoscopy, robotic assisted surgery, and image guided interventions, the comparison of minimally invasive surgery to conventional open surgery with regards to cancer control and impact on the quality of life, and the implementation of quality outcome metrics to objectively measure and assess surgical performance. His laboratory research focuses on studying lymph node metastases for genitourinary malignancies using cancer targeted nanotechnology probes.
After a fellowship in urologic oncology and advanced laparoscopic oncology at MSKCC, he joined the MSKCC Urology faculty in 2004. Dr. Touijer is completing a Master's in Public Health from the Harvard School of Public Health.
He is board certified by the American Board of Urology, Fellow of the American College of Surgeons and member of the Society of Urologic Oncology, the American Urological Association, the European Association of Urology, the American Society of Clinical Oncology and other national and international societies; additionally he serves on the editorial board and as a reviewer of a number of peer-reviewed urology and cancer journals. Dr. Touijer has authored over 100 peer-reviewed journal articles and book chapters. He is the editor of a book chapter on the management of genito-urinary malignancies and a regular visiting professor and guest speaker to numerous meetings and symposia around the world.
J. Stuart Wolf, Jr., MD, FACS
Sub-Specialty Areas: Endourology, Urinary Stone Disease, Laparoscopy, and Practice Guidelines
After receiving his M.D. degree from Northwestern University, Dr. Wolf completed urology residency at the University of California (San Francisco), followed by a Fellowship in St. Louis. He joined the University of Michigan faculty in July of 1996 as the Director of the Division of Endourology and Stone Disease, has co-directed the Urologic Oncology and Endourology/Laparoscopy Fellowship at the University of Michigan since 2002, and is the Associate Department Chair for Clinical Operations. Involved in professional activities at the regional, national and international levels, Dr. Wolf serves on the Executive Committee of the Michigan Urologic Society, is the Chair of the AUA Practice Guidelines Committee, and sits on the Board of Directors of the Endourological Society. The author of more than 200 scientific articles and 125 invited publications, Dr. Wolf has served on the editorial boards of eleven journals, including the Journal of Endourology and the Journal of Urology.
Gerald Brock, MD, FRCSC
Sub-Specialty Areas: Peyronie's Disease, Hypogonadism, Penile Rehabilitation, PDE5i physiology, Evolving areas of sexual health
Gerald Brock is a Professor in the Division of Urology, Department of Surgery at the University of Western Ontario, London Ontario Canada where he serves as Urology Program Director. He runs an active tertiary clinical / surgical practice where he sees approximately 1500 new consultants for ED and sexual dysfunction annually. In addition to his teaching responsibilities, he serves as Chair of the Canadian Urology Association's (CUA) Office of Education, secretary of the Sexual Medicine Society of North America and research chair of the Canadian Society for the Study of the Aging Male. Dr Brock runs a productive basic science research lab evaluating the effects of disease states (Diabetes, hypogonadism and surgical trauma) on erectile mechanisms using animal models. He is the author of over 150 per reviewed publications, 23 book chapters and the recipient of over 20 National and International research awards.
Mostafa M. Elhilali, MD, PhD, FRCSC
Sub-Specialty Areas: BPH, Medical management of BPH, Laser surgery, Prostate cancer, Neurourology, Stones, Endourology
Dr. Elhilali was born in Egypt and graduated from Cairo University in 1959. He trained at Cairo University and obtained his Ph.D. at McGill University. He became a fellow of the Royal College of Surgeons of Canada in 1969. His professional positions and awards include:
Chairman, Department of Urology Sherbrooke University, 1975-1983
Chairman, Dept. of Urology, McGill University, 1982-2002
Chairman, Department of Surgery McGill University, 2002-2009
Surgeon-in-Chief, McGill University Health Centre, 2002-2009
President Canadian Urological Association, 1992-1993
President, Northeast Section of AUA, 1994-1995
General Secretary Société International d'urologie SIU, 1998-2006
President Société International d'urologie SIU, 2007-2009
Stephen Jarislowsky Chair of Urology (McGill University 1992)
Honorary President of the Egyptian Urological Association
Officer of the Order of Canada – 2002
AUA Distinguished Contributions Award, 2003
Kidney Foundation of Canada Founder's Award 2005
AUA Lifetime Achievements Award, April 2009
Officer of the Order of Quebec – 2009
Fellow, American Association of Genitourinary Surgeons
Guest Speaker and Visiting Professor 162 times
Supervised National and International fellows for post doctoral
Fellowship and master or doctorate thesis for 46 students
Published 242 papers in peer reviewed journals.
17 Book Chapters
John D. Denstedt, MD, FRCSC, FACS
Sub-Specialty Areas: Minimally Invasive Surgery, Urolithiasis, Biomaterials, Urinary Tract Infection
Dr. John Denstedt graduated from medical school at The University of Western Ontario. He completed his residency in Urology at Western between 1983 and 1987 followed by a fellowship in Endourology under Dr. Ralph Clayman at Washington University in St. Louis. He returned to London and joined the Division of Urology in the Department of Surgery at Western in 1990.
In July 2003 he assumed the role of City-Wide Chair and Chief of the Department of Surgery at The University of Western Ontario, and was re-appointed in 2008 for another 5-year term. Dr. Denstedt also currently serves as the Integrated Senior Medical Director of Surgery Services, at London Health Sciences Centre & St. Joseph's Health Care, London and is currently the Chair of the Canadian Association of Surgical Chairs.
While maintaining an active clinical practice, Dr. Denstedt is an internationally renowned scholar in urology with career accomplishments encompassing over 175 publications; more than 200 guest professorships in countries throughout the world; and numerous honours and awards including being the first Canadian to have won the Gold Cystoscope Award from the American Urological Association (AUA). Dr. Denstedt's research interests include minimally invasive surgery; urolithiasis; biomaterials; and urinary tract infection. With a specific interest in surgical education, he has participated in the development and validation of computer based surgical simulators, which help train the next generation of surgeons.
Martin Gleave MD, FRCSC, FACS
Sub-Specialty Areas: Oncology – Prostate, Bladder; Therapeutic Interventions, Gene Therapy, PSA
Dr. Gleave is a Distinguished Professor in the Department of Urologic Sciences at the University of British Columbia, Director of the Vancouver Prostate Center, and Director of Research for the Department of Urologic Sciences at UBC. He is the past Chair of the National Cancer Institute of Canada GU Clinical Trials Group, and the Canadian Uro-Oncology Group. He has published > 300 peer-reviewed papers and received more than $60M in peer reviewed research funding. Dr. Gleave's research focuses on study of molecular mechanisms mediating progression of prostate cancer to its lethal stage of castrate resistance, and use of this information to develop integrated multimodality therapies. His research team employs high-throughput approaches to target discovery, validation, credentialization, and therapeutic development. He has characterized the role of many genes in cancer progression, leading to several patented targeted inhibitors and first-in-man trials of new anti-cancer drugs. Dr. Gleave established a role for clusterin as an cancer-related cell survival protein involved treatment resistance and developed an inhibitor, OGX-011, that improved efficacy of hormone- and chemo-therapies in prostate and other cancer models. 7 clinical studies across North America have been completed, including a randomized trial demonstrating a 7 month gain in overall survival when OGX-011 was combined with docetaxel. Two Phase III registration trials with OGX-011 began in 2010. Additional targeted agents have been developed against IGFBP2, IGFBP-5, and Hsp27 in various stages of preclinical and early clinical development. Intellectual property from these targets has been licensed from UBC to OncoGenex Technologies, a Nasdaq-listed biotechnology company founded by Dr. Gleave. Dr. Gleave is the Chief Scientific Officer at OncoGenex, while retaining his Professorship and laboratory at UBC.
Dr. Gleave is the recipient of numerous awards, including the NCIC's prestigious William Rawls Award for contributions to cancer control in Canada, the Society of Urologic Oncology's Young Investigator Award, Finalist, Ernst and Young Entrepreneur of the Year, 2004, and Clinician-Scientist Award, Prostate Cancer Foundation. In 2003, he was appointed a Distinguished University Scholar at the University of British Columbia, and a BC Leadership Chair through the Province of BC's Leading Edge Endowment Fund in 2005. Dr. Gleave was awarded the 2006 BC Biotech Award for Innovation and Achievement, and the 2007 BC Innovation Council Frontiers in Research Award.
Sender Herschorn, BSc, MDCM, FRCSC
Sub-Specialty Areas: Male Incontinence, Female Incontinence and Pelvic Floor Dysfunction, Overactive Bladder, Neurogenic Bladder, Urologic Reconstruction and Diversion
Dr. Sender Herschorn is Professor and Chair of Urology at the University of Toronto and Urologist at Sunnybrook Health Sciences Centre. He holds the Martin Barkin Chair in Urological Research and chairs the Department of Surgery Academic Promotions Committee.
Dr. Herschorn has conducted clinical trials in urinary incontinence, overactive bladder, and erectile dysfunction. He has won education awards at the University of Toronto as well as the Zimskind Award of the Society for Urodynamics and Female Urology. He is the 2010 recipient of the Lifetime Achievement Award from the Society for Urodynamics and Female Urology. He is Past-President of the Canadian Urological Association. He was recently elected General Secretary of the International Continence Society.
Dr. Herschorn is an Editorial Board Member of Canadian Urological Association Journal and Neurourology and Urodynamics. He has chaired various committees at the International Consultations on Incontinence and Urethral Stricture Disease. He has also lectured widely.
Michael A.S. Jewett, MD, FRCSC, FACS
Sub-Specialty Areas: UroOncology with special interests in Kidney, Testis and Bladder Cancer
Dr. Michael Jewett is a Professor of Surgery(Urology) at the University of Toronto. He is the immediate past Chairman and Program Director of the Division of Urology at the University of Toronto and Head of Urology at the University Health Network which incorporates the Princess Margaret Hospital cancer centre. He is a past president of the Canadian Urology Association. Dr. Jewett holds 2 academic Chairs, one from the Canadian Institutes of Health Research, and is currently the Farquaharson Clinical Research Chair in Oncology. He holds extensive peer reviewed funding and has published more that 250 peer reviewed papers. His research is currently focused in kidney cancer and has published extensively in this field as well as in other UroOncology subjects. He has had a career long interest in testicular cancer with multiple papers and involvement in consensus statements. He is a member of he new NCI Renal Task Force. In 2011, he was awarded the AUA Distinguished Contribution Award, the SUO Medal, the CUA Award and the Postgraduate Teaching Award by UofT Urology for best surgical teacher.
Patrick P. W. Luke, MD, FRCSC
Sub-Specialty Areas: Transplantation, Robotic Renal Surgery, Laparoscopic Surgery
Patrick Luke is an Associate Professor of Surgery and the co-Director of the Multiorgan Transplant Program at the London Health Sciences Centre. He completed his residency at the University of Western Ontario, fellowship at the University of Pittsburgh and has been an attending surgeon at LHSC since 2000. He was selected as one of Canada's 'Top 40 Under 40' by Caldwell Partners' and the Globe and Mail in 2005 and is the 2010 recepient of the American Urologic Association Gold Cystoscope Award, presented to the urologist distinguished by outstanding contributions to the profession within 13 years of completing residency training. Over the last decade, he has published over 80 original papers and book chapters. His clinical research interests include kidney/pancreas transplantation and advanced surgical techniques (robotics, telesurgery, telementoring, laparoscopy). His basic science research involves immunotherapy, organ preservation and optimization of organ function post-transplant. He serves on a number of committees affiliated with the Canadian Society of Transplantation and the American Urologic Association. He is also the section editor for Minimally Invasive Surgery/ Image Guided Therapy for the CUA Journal and is an ad hoc reviewer for a dozen journals including Lancet and the American Journal of Transplantation.
The transplant surgery fellowship program at the University of Western Ontario is the only American Society of Transplant Surgery approved program in renal transplantation in Canada. The Multiorgan Transplant Program at UWO was also awarded the Dean's Award of Excellence in 2007.
J. Curtis Nickel MD, FRCSC
Sub-Specialty Areas: Prostatitis/Chronic Pelvic Pain Syndrome, Interstitial Cystitis/Bladder Pain Syndrome, and Benign Prostatic Hyperplasia
Dr. Nickel's research has been in the fields of inflammatory diseases of the urinary tract and benign diseases of the prostate gland. He has written over 450 scientific papers, reviews, chapters and books on these subjects and is funded in part by the US NIH/NIDDK and Canadian CIHR. He has given invited lectures in over forty countries. He is on the scientific or review panel of numerous granting agencies, a regular reviewer for over a dozen urological and medical journals, on the editorial board of eight national and international urological journals, was on the examination boards of both the American Board of Urology and the Royal College of Canada and is a member of the many national and international research consortia. He was recently awarded a CIHR Tier I Canada Research Chair in Urologic Pain and Inflammation and the AUA 2009 Distinguished Contribution Award.
Joao Luiz Pippi Salle, MD, PhD, FRCSC, FAAP
Sub-Specialty Areas: Pediatric Urology
Dr. Joao Luiz Pippi Salle is currently the Head of the Division of Urology at The Hospital for Sick Children and a Professor with the Department of Surgery at the University of Toronto.
In 1995, Dr. Salle joined the Division of Urology at Sick Kids as an Associate Staff member. From 1996 to 2003, he served as Chief of the Division of Urology at The Montreal Children's Hospital and an Associate Professor of Surgery at McGill University.
Dr. Salle is world renowned for his innovative surgical skills. He has created new approaches to tackling difficult areas of pediatric urology such as refractory urinary incontinence, feminizing genitoplasty, hypospadias repair and well as other reconstructive procedure for bladder exstrophy and epispadias.
He is a highly sought after educator, guest speaking and performing demonstrative live surgery in over 150 invitations. He has published 60 papers in peer-reviewed journals and authored 25 book chapters. He is currently in the process of developing a CD-ROM for teaching pediatric urology to fellows and residents.
Jorge Gutierrez-Aceves, MD
Sub-Specialty Areas: Endourology, Minimally Invasive Endoscopic Surgery
Head of the training center on advanced Endourology and Robotic Surgery, Endourological Society recognized program, at Centro Medico Puerta de Hierro, affiliated hospital to the Universities Instituto Superior de Estudios Superiores de Monterrey and University of Guadalajara.
Associate Professor of Urology at the University of Guadalajara and former Chairman of the Department of Urology at Nuevo Hospital Civil, University of Guadalajara from 1995-2011.
President of the Sociedad Mexicana de Urologia (SMU) from 2000-2001.
Member of the board and Secretary of Education of the Confederation Americana de Urologia (CAU).
Member of more than 10 different Urological Society, including honorary membership in 5 different Latin-American Societies and international member of the American Association of Genitourinary Surgeons.
Areas of clinical interest include the minimally invasive management of urinary stones, minimally invasive management of BPH and robotic surgery.
Continuous teaching experiences in different scientific activities in Latin America.
Mariano Sotomayor, MD
Sub-Specialty Areas: Sexual Dysfunction
Dr. Mariano Sotomayor graduated from Universidad Michoacana de San Nicolás de Hidalgo Medical School in 1984, after that, he completed residences in Internal Medicine, General Surgery and Urology at the National Institute of Medical Sciences and Nutrition in Mexico City, currently he is staff member of the department of Urology and coordinator of the Sexual Dysfunction Clinic at the same institution. He is professor of Urology for the Universidad Nacional Autónoma de México and member of many medical societies including the International Society for Impotence Research, the International Society of Urology, the American Urological Association, the Latin American Society for Impotence Research, amongst others. He has served on the board of directors of the Sociedad Mexicana de Urología, the Latin American Society for Impotence Research, the editorial board of the Journal of Sexual Medicine and currently he is the secretary of the Mexican Society of Urology and member of the editorial board of the Revista de Investigación Clínica. He is the author of many book chapters and articles published in national and international journals.